Item 5.02. Departure of Directors or Certain Officers; Election of Directors:
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 1, 2009, the board of directors of Inverness Medical Innovations, Inc. (the "Company") elected Eli Y. Adashi, M.D., MS, FACOG, to serve as a Class III member of the board of directors of the Company. He was also appointed to serve as a member of the board's compensation committee. Dr. Adashi was determined to be "independent" under the independence standards of the New York Stock Exchange.
As compensation for his services as a director for the next year, Dr. Adashi will receive cash compensation of $75,000, payable quarterly in arrears, and an option to purchase 8,000 shares of the Company's common stock. The option, which will vest over 3 years in equal installments, will be granted as of the next grant date under the Company's Stock Option Granting Policy and will have an exercise price equal to the closing price of the Company's common stock on the New York Stock Exchange on the grant date.

---

Table of Contents